$MTD

METTLER TOLEDO INTERNATIONAL INC/

Mettler-Toledo supplies precision instruments and related services to customers in industries including life sciences, food, chemicals, manufacturing, transportation and logistics, and food retail. Its five reportable segments are U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other Operations. Its products include laboratory balances, pipettes, analytical and process measurement instruments, industrial weighing equipment, product inspection systems, and retail weighing solutions. It also offers software platforms, including LabX, and services such as calibration, maintenance, regulatory compliance support, and replacement parts. Mettler-Toledo sells through direct and indirect channels, with sales through direct channels exceeding those through indirect channels. It makes money from instrument and software sales and from services, including service contracts, on-demand work, and replacement parts. Its products are sold in more than 140 countries, and it has a direct presence in approximately 40 countries. Mettler-Toledo is headquartered in Columbus, Ohio.

AlphAI earnings readThird quarter 2026 · NOV 5METTLER-TOLEDO INTERNATIONAL INC. REPORTS THIRD QUARTER 2026 RESULTSVerdict: strong

Reads like this one publish minutes after the filing lands on EDGAR. Get them as JSON over the API or inside your AI agent over MCP.

No enriched coverage for $MTD in the last 7 days.

—
$754K
Keller Gerry
0%
See all $MTD insider activity →
Med

Biotech funding froze. Why has this lab instrument maker climbed 25% anyway? By Investing.com RSS CTA

Mettler-Toledo International (MTD) has risen 25.2% in two months, defying a biotech funding slowdown. The company, a key supplier of precision lab instruments, benefits from regulatory requirements in commercial drug production. Q3 results showed $1.09B revenue, $12.57 adjusted EPS, and strong margins. Management's 2026-2027 EPS guidance exceeds Wall Street estimates, with free cash flow supporting share buybacks.

MTD sentiment & insider activity

Recent MTD coverage spans financial news, earnings and insider activity.

In the last 30 days, MTD insiders filed 2 SEC Form 4 transactions — no purchases and 2 sales ($754K). The most active reporter was Keller Gerry, Head of Process Analytics, with 2 filings.

What's driving MTD

AlphAI scores every news story that mentions MTD with an AI model for sentiment and relevance, and aggregates insider trades from METTLER TOLEDO INTERNATIONAL INC/'s SEC EDGAR Form 4 filings. Figures refresh continuously.

News on $MTD

Score

Biotech funding froze. Why has this lab instrument maker climbed 25% anyway? By Investing.com RSS CTA

Mettler-Toledo International (MTD) has risen 25.2% in two months, defying a biotech funding slowdown. The company, a key supplier of precision lab instruments, benefits from regulatory requirements in commercial drug production. Q3 results showed $1.09B revenue, $12.57 adjusted EPS, and strong margins. Management's 2026-2027 EPS guidance exceeds Wall Street estimates, with free cash flow supporting share buybacks.

What Mettler-Toledo International (MTD) Said on Its Q3 Earnings Call

Mettler-Toledo (MTD) reported Q3 gross margin expansion to 59.8% and adjusted operating profit growth of 8%. The company raised its 2026 sales growth forecast to 5% and issued 2027 guidance, expecting 5% sales growth and adjusted EPS of $52.50-$53.50. Management highlighted opportunities in automation, digitalization, and U.S. onshoring, with potential upside from AI-driven instrument upgrades.

Related tickers